Simplified Chinese
scroll down
25
2025-11
From Strategy to Execution: External Expertise Empowers Management
To comprehensively enhance the strategic thinking and operational coordination capabilities of mid- to senior-level management, thereby solidifying the managerial foundation for the company’s future development, Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as “Minhai Bio”) successfully held a specialized training session on strategic operations management on November 4, 2025. The event featured renowned guest instructor Mr. Shawn, a former senior strategic management expert at Company H, who delivered an engaging lecture. Minhai Kangtai’s management team participated in an intellectual feast exploring the journey from strategy formulation to execution and implementation. With the core objectives of “deepening strategic understanding, optimizing operational processes, and reinforcing results‑oriented management,” this training aimed to provide systematic theoretical instruction and in‑depth analysis of real‑world case studies.
25
2025-11
On the morning of November 15, 2025, the “2025 Academician and Expert Roundtable Salon—Vaccine Development and Challenges for Hospital-Acquired Bacterial Infections,” hosted by the Innovation Service Center of the Beijing Association for Science and Technology and co-organized by the Daxing District Association for Science and Technology, the Management Committee of the Daxing Biopharmaceutical Industry Base of the Zhongguancun Science Park, and Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as “Minhai Bio”), was successfully held at Minhai Bio’s Internationalization Industrial Base for Novel Vaccines. The event focused on the increasingly pressing global public health challenge of hospital-acquired bacterial infections (HABI), bringing together academicians of the Chinese Academy of Engineering, renowned university scholars, and national-level researchers…
04
2025-09
Remember history, honor our heroes; strengthen our national defense, and rejuvenate the Chinese nation. On the morning of September 3, 2025, a grand commemorative rally marking the 80th anniversary of the victory of the Chinese People’s War of Resistance Against Japanese Aggression and the World Anti-Fascist War was solemnly held at Tiananmen Square in Beijing. Minhai Biotechnology promptly issued a notice, organizing all employees to gather in the multi-purpose conference hall to watch the live broadcast of the military parade, jointly witnessing this solemn and inspiring historical moment. The event aimed to guide employees in deeply commemorating the outstanding achievements of revolutionary martyrs, truly appreciating the nation’s growing comprehensive strength and the remarkable accomplishments of its modernized national defense, thereby further igniting patriotic enthusiasm and rallying collective momentum for progress. During the broadcast, all employees…
28
2025-08
Recently, Shenzhen Kangtai Biological Products Co., Ltd. has launched a research and development project for a globally innovative vaccine—Pneumonia‑causing Klebsiella pneumoniae vaccine. Kangtai Biologics will actively advance preclinical studies, clinical trials, and subsequent industrialization efforts for this vaccine. Klebsiella pneumoniae is currently one of the most drug‑resistant and virulent bacteria in clinical practice, often referred to as the “king of superbugs.” In particular, carbapenem‑resistant Klebsiella pneumoniae (CRKP) exhibits resistance to virtually all first‑ and second‑line antibiotics. According to the 2024 National Hospital‑Acquired Infection Prevalence Survey Report (12th edition), Klebsiella pneumoniae remains the pathogen with the highest detection rate.
25
2025-08
On July 28, 2025, the first Biopharmaceutical Base Safety Production Competition concluded successfully. Relying on solid safety knowledge, expert operational skills, and outstanding team collaboration, Minhai Biotechnology won the prestigious first-place award in the highly competitive confined-space operations event. This achievement fully demonstrates Minhai Biotechnology’s exceptional management standards in the field of workplace safety—particularly in high-risk operations—and its employees’ robust, real-world capabilities. The inaugural Safety Production Competition was meticulously organized by the Daxing District Biopharmaceutical Base Management Committee, featuring four key disciplines: fire emergency response, hazard identification, confined-space operations, and electrical safety, with the aim of comprehensively enhancing safety across the entire industrial park.
Contact Information
Customer Service Hotline
4001899806
Phone number
010-59613600
Official Website
Company Address
No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
WeChat Official Account
0
%